MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily Gold Miners Bull 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

Direxion Daily 20+ Yr Trsy Bull 3X ETF

ProShares Ultra Silver

T-REX 2X Inverse Tesla Daily Target ETF

Direxion Daily Semicondct Bear 3X ETF

VanEck Vectors Junior Gold Miners ETF

VanEck Vectors Gold Miners ETF

GraniteShares 1.5x Long Coinbase Daily ETF

Mast Therapeutics, Inc.

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

GraniteShares 1.5x Long META Daily ETF

Volatility Shares Trust 2x Ether ETF

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily Gold Miners Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

GraniteShares 2x Long AMZN Daily ETF

iShares Ethereum Trust ETF

Click Holdings Limited Ordinary Share

Foot Locker Inc.

Aytu BioPharma Inc.  Common Stock

Kindly MD Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

LOBO EV TECHNOLOGIES LTD. Ordinary shares

Next Technology Holding Inc. Ordinary Shares

SolarEdge Technologies Inc. Common Stock

Siyata Mobile Inc. Common Shares

Asset Entities Inc. Class B Common Stock

Incannex Healthcare Limited American Depositary Shares

Crown LNG Holdings Limited Ordinary Shares

Luminar Technologies Inc.  Class A Common Stock

MicroAlgo Inc. Ordinary Shares

Dick's Sporting Goods Inc Common Stock

Plug Power Inc. Common Stock

Theriva Biologics Inc. Common Stock

UnitedHealth Group Incorporated Common Stock (DE)

ScanTech AI Systems Inc. Common stock

Freight Technologies Inc. Ordinary Shares

Click here to get full coverage on MannKind CMO steps down, transition plan set - Investing.com

MannKind CMO steps down, transition plan set  Investing.com

MannKind CMO steps down, transition plan set - Investing.com

Click here to get full coverage on MannKind Announces CMO Transition and Separation Agreement - TipRanks

MannKind Announces CMO Transition and Separation Agreement  TipRanks

MannKind Announces CMO Transition and Separation Agreement - TipRanks

Click here to get full coverage on MannKind to Present at Upcoming Investor Conferences - GlobeNewswire

MannKind to Present at Upcoming Investor Conferences  GlobeNewswire

MannKind to Present at Upcoming Investor Conferences - GlobeNewswire

Click here to get full coverage on MannKind CEO to Share Strategic Updates at Two Major Healthcare Conferences This Month - Stock Titan

MannKind CEO to Share Strategic Updates at Two Major Healthcare Conferences This Month  Stock Titan

MannKind CEO to Share Strategic Updates at Two Major Healthcare Conferences This Month - Stock Titan

Click here to get full coverage on MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain  Yahoo Finance

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

Click here to get full coverage on Earnings Miss: MannKind Corporation Missed EPS By 5.9% And Analysts Are Revising Their Forecasts - simplywall.st

Earnings Miss: MannKind Corporation Missed EPS By 5.9% And Analysts Are Revising Their Forecasts  simplywall.st

Earnings Miss: MannKind Corporation Missed EPS By 5.9% And Analysts Are Revising Their Forecasts - simplywall.st

Click here to get full coverage on MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript - Insider Monkey

MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript  Insider Monkey

MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update  GlobeNewswire

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Click here to get full coverage on MannKind Sets Q1 2025 Earnings Date: CEO and CFO to Present Latest Financial Results - Stock Titan

MannKind Sets Q1 2025 Earnings Date: CEO and CFO to Present Latest Financial Results  Stock Titan

MannKind Sets Q1 2025 Earnings Date: CEO and CFO to Present Latest Financial Results - Stock Titan

Click here to get full coverage on Is MannKind Corporation (MNKD) the Best Quality Penny Stock to Buy According to Hedge Funds? (READY TO EDIT2) - Yahoo Finance

Is MannKind Corporation (MNKD) the Best Quality Penny Stock to Buy According to Hedge Funds? (READY TO EDIT2)  Yahoo Finance

Is MannKind Corporation (MNKD) the Best Quality Penny Stock to Buy According to Hedge Funds? (READY TO EDIT2) - Yahoo Finance

Click here to get full coverage on MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates  Yahoo Finance

MannKind (MNKD) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update  GlobeNewswire

MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Click here to get full coverage on Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds?  Yahoo Finance

Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Yahoo Finance

Click here to get full coverage on MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Expect  Yahoo Finance

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance

Click here to get full coverage on MannKind Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance

MannKind Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now  Yahoo Finance

MannKind Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance

Click here to get full coverage on Compared to Estimates, MannKind (MNKD) Q4 Earnings: A Look at Key Metrics - Nasdaq

Compared to Estimates, MannKind (MNKD) Q4 Earnings: A Look at Key Metrics  Nasdaq

Compared to Estimates, MannKind (MNKD) Q4 Earnings: A Look at Key Metrics - Nasdaq

Click here to get full coverage on Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10 - Yahoo Finance

Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10  Yahoo Finance

Here’s Why MannKind Corporation (NASDAQ:MNKD) Is Among the Best Diabetes Stocks to Buy Under $10 - Yahoo Finance

Click here to get full coverage on MNKD - Mannkind Latest Stock News & Market Updates - Stock Titan

MNKD - Mannkind Latest Stock News & Market Updates  Stock Titan

MNKD - Mannkind Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22 - GlobeNewswire

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22  GlobeNewswire

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22 - GlobeNewswire

Click here to get full coverage on MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run?  Yahoo Finance

MannKind Corporation (MNKD) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance

Click here to get full coverage on MannKind (MNKD) Q4 Earnings Meet Estimates - Yahoo Finance

MannKind (MNKD) Q4 Earnings Meet Estimates  Yahoo Finance

MannKind (MNKD) Q4 Earnings Meet Estimates - Yahoo Finance

Click here to get full coverage on MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...  Yahoo Finance

MannKind Corp (MNKD) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Click here to get full coverage on Mizuho sets MannKind stock Outperform with $12 target - Investing.com

Mizuho sets MannKind stock Outperform with $12 target  Investing.com

Mizuho sets MannKind stock Outperform with $12 target - Investing.com

Click here to get full coverage on MannKind: Q1 Earnings Snapshot - Midland Daily News

MannKind: Q1 Earnings Snapshot  Midland Daily News

MannKind: Q1 Earnings Snapshot - Midland Daily News

Click here to get full coverage on Despite shrinking by US$88m in the past week, MannKind (NASDAQ:MNKD) shareholders are still up 309% over 5 years - simplywall.st

Despite shrinking by US$88m in the past week, MannKind (NASDAQ:MNKD) shareholders are still up 309% over 5 years  simplywall.st

Despite shrinking by US$88m in the past week, MannKind (NASDAQ:MNKD) shareholders are still up 309% over 5 years - simplywall.st

Click here to get full coverage on MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years - Yahoo Finance

MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years  Yahoo Finance

MannKind (NASDAQ:MNKD) pulls back 3.8% this week, but still delivers shareholders fantastic 36% CAGR over 5 years - Yahoo Finance

Click here to get full coverage on MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Look For  Yahoo Finance

MannKind Corp (MNKD) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Click here to get full coverage on Diabetes Meets Racing: MannKind's Game-Changing Partnership With Type 1 Diabetic IndyCar Star - Stock Titan

Diabetes Meets Racing: MannKind's Game-Changing Partnership With Type 1 Diabetic IndyCar Star  Stock Titan

Diabetes Meets Racing: MannKind's Game-Changing Partnership With Type 1 Diabetic IndyCar Star - Stock Titan

Click here to get full coverage on MannKind Announces Six-Month Results From Phase 3 - GlobeNewswire

MannKind Announces Six-Month Results From Phase 3  GlobeNewswire

MannKind Announces Six-Month Results From Phase 3 - GlobeNewswire

Click here to get full coverage on MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash - Yahoo Finance

MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash  Yahoo Finance

MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash - Yahoo Finance

Click here to get full coverage on MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Growth | MNKD Stock News - GuruFocus

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Growth | MNKD Stock News  GuruFocus

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Growth | MNKD Stock News - GuruFocus

Click here to get full coverage on MannKind’s Strong Financial Performance and Promising Pipeline Drive Buy Rating - TipRanks

MannKind’s Strong Financial Performance and Promising Pipeline Drive Buy Rating  TipRanks

MannKind’s Strong Financial Performance and Promising Pipeline Drive Buy Rating - TipRanks

Click here to get full coverage on MannKind: Q1 Earnings Snapshot - Huron Daily Tribune

MannKind: Q1 Earnings Snapshot  Huron Daily Tribune

MannKind: Q1 Earnings Snapshot - Huron Daily Tribune

Click here to get full coverage on MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...  Yahoo Finance

MannKind Corp (MNKD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Click here to get full coverage on (02/03/25) Top Picks 2025: MannKind (MNKD) - moneyshow.com

(02/03/25) Top Picks 2025: MannKind (MNKD)  moneyshow.com

(02/03/25) Top Picks 2025: MannKind (MNKD) - moneyshow.com

Click here to get full coverage on MannKind Corporation Reports Strong Q1 2025 Results - TipRanks

MannKind Corporation Reports Strong Q1 2025 Results  TipRanks

MannKind Corporation Reports Strong Q1 2025 Results - TipRanks

Click here to get full coverage on Strong Revenue Growth and Market Expansion Drive Buy Rating for MannKind - TipRanks

Strong Revenue Growth and Market Expansion Drive Buy Rating for MannKind  TipRanks

Strong Revenue Growth and Market Expansion Drive Buy Rating for MannKind - TipRanks

Click here to get full coverage on Earnings Flash (MNKD) MANNKIND Reports Q1 Revenue $78.4M, vs. FactSet Est of $76.0M - marketscreener.com

Earnings Flash (MNKD) MANNKIND Reports Q1 Revenue $78.4M, vs. FactSet Est of $76.0M  marketscreener.com

Earnings Flash (MNKD) MANNKIND Reports Q1 Revenue $78.4M, vs. FactSet Est of $76.0M - marketscreener.com

Click here to get full coverage on MannKind Corporation Reports First Quarter 2025 Financial Results - TradingView

MannKind Corporation Reports First Quarter 2025 Financial Results  TradingView

MannKind Corporation Reports First Quarter 2025 Financial Results - TradingView

Click here to get full coverage on Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight  GuruFocus

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus

Click here to get full coverage on MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver - GlobeNewswire

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver  GlobeNewswire

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver - GlobeNewswire

Click here to get full coverage on MannKind: Q1 Earnings Snapshot - San Francisco Chronicle

MannKind: Q1 Earnings Snapshot  San Francisco Chronicle

MannKind: Q1 Earnings Snapshot - San Francisco Chronicle

Click here to get full coverage on MannKind Shares Are falling Today: What's Going On? - Benzinga

MannKind Shares Are falling Today: What's Going On?  Benzinga

MannKind Shares Are falling Today: What's Going On? - Benzinga

Click here to get full coverage on MannKind Corp (MNKD) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance

MannKind Corp (MNKD) Q4 2024 Earnings Report Preview: What To Expect  Yahoo Finance

MannKind Corp (MNKD) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Click here to get full coverage on MannKind Corporation's (NASDAQ:MNKD) Share Price Boosted 28% But Its Business Prospects Need A Lift Too - simplywall.st

MannKind Corporation's (NASDAQ:MNKD) Share Price Boosted 28% But Its Business Prospects Need A Lift Too  simplywall.st

MannKind Corporation's (NASDAQ:MNKD) Share Price Boosted 28% But Its Business Prospects Need A Lift Too - simplywall.st

Click here to get full coverage on MannKind Expands Executive Leadership Team - GlobeNewswire

MannKind Expands Executive Leadership Team  GlobeNewswire

MannKind Expands Executive Leadership Team - GlobeNewswire

Click here to get full coverage on MANNKIND CORP SEC 10-Q Report - TradingView

MANNKIND CORP SEC 10-Q Report  TradingView

MANNKIND CORP SEC 10-Q Report - TradingView

Click here to get full coverage on MannKind Strengthens Leadership Team with Endocrine Business Unit President Appointment - Stock Titan

MannKind Strengthens Leadership Team with Endocrine Business Unit President Appointment  Stock Titan

MannKind Strengthens Leadership Team with Endocrine Business Unit President Appointment - Stock Titan

Click here to get full coverage on Promising Clinical Data and Market Potential Drive Buy Rating for MannKind’s Afrezza - TipRanks

Promising Clinical Data and Market Potential Drive Buy Rating for MannKind’s Afrezza  TipRanks

Promising Clinical Data and Market Potential Drive Buy Rating for MannKind’s Afrezza - TipRanks

Click here to get full coverage on MNKD-201, inhaled nintedanib for IPF, found safe in healthy people - Pulmonary Fibrosis News

MNKD-201, inhaled nintedanib for IPF, found safe in healthy people  Pulmonary Fibrosis News

MNKD-201, inhaled nintedanib for IPF, found safe in healthy people - Pulmonary Fibrosis News

Click here to get full coverage on Mannkind stock gains amid Q4 report, business update (MNKD:NASDAQ) - Seeking Alpha

Mannkind stock gains amid Q4 report, business update (MNKD:NASDAQ)  Seeking Alpha

Mannkind stock gains amid Q4 report, business update (MNKD:NASDAQ) - Seeking Alpha

Click here to get full coverage on MannKind Corporation: A Speculative Buy On IPF And Diabetes Markets - Seeking Alpha

MannKind Corporation: A Speculative Buy On IPF And Diabetes Markets  Seeking Alpha

MannKind Corporation: A Speculative Buy On IPF And Diabetes Markets - Seeking Alpha

Click here to get full coverage on MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update | MNKD Stock News - GuruFocus

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update | MNKD Stock News  GuruFocus

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update | MNKD Stock News - GuruFocus

Click here to get full coverage on (MNKD) Technical Pivots with Risk Controls - news.stocktradersdaily.com

(MNKD) Technical Pivots with Risk Controls  news.stocktradersdaily.com

MannKind Corp (MNKD)

Price Chart

Key Statistics

Technicals

About MNKD

Latest News

MannKind CMO steps down, transition plan set - Investing.com

MannKind Announces CMO Transition and Separation Agreement - TipRanks

MannKind to Present at Upcoming Investor Conferences - GlobeNewswire

Advanced Charts

Top Gainers

Top Losers